Free Trial

Ardent Health Partners (NYSE:ARDT) Hits New 1-Year Low - Here's What Happened

Ardent Health Partners logo with Medical background
Remove Ads

Ardent Health Partners, LLC (NYSE:ARDT - Get Free Report)'s share price reached a new 52-week low on Thursday . The stock traded as low as $12.34 and last traded at $12.84, with a volume of 617968 shares traded. The stock had previously closed at $12.97.

Wall Street Analysts Forecast Growth

ARDT has been the topic of a number of recent analyst reports. Royal Bank of Canada cut their price target on shares of Ardent Health Partners from $23.00 to $21.00 and set an "outperform" rating on the stock in a report on Tuesday, March 4th. Truist Financial reduced their target price on Ardent Health Partners from $22.00 to $21.00 and set a "buy" rating for the company in a report on Monday, January 6th. Stephens reaffirmed an "overweight" rating and issued a $22.00 target price on shares of Ardent Health Partners in a research report on Tuesday, April 1st. Morgan Stanley dropped their price target on Ardent Health Partners from $23.50 to $22.00 and set an "overweight" rating on the stock in a research report on Tuesday, January 21st. Finally, JPMorgan Chase & Co. restated a "neutral" rating and set a $20.00 price objective on shares of Ardent Health Partners in a research report on Tuesday, December 17th. Two equities research analysts have rated the stock with a hold rating, eight have given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the stock has an average rating of "Buy" and a consensus price target of $21.18.

Check Out Our Latest Research Report on Ardent Health Partners

Ardent Health Partners Stock Performance

The firm's 50-day moving average is $14.19 and its two-hundred day moving average is $16.01. The company has a current ratio of 1.91, a quick ratio of 1.78 and a debt-to-equity ratio of 0.78.

Remove Ads

Ardent Health Partners (NYSE:ARDT - Get Free Report) last posted its earnings results on Wednesday, February 26th. The company reported $0.81 EPS for the quarter, topping the consensus estimate of $0.50 by $0.31. The business had revenue of $1.61 billion for the quarter, compared to analyst estimates of $1.48 billion. Analysts predict that Ardent Health Partners, LLC will post 1.23 earnings per share for the current year.

Institutional Investors Weigh In On Ardent Health Partners

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Point72 Asia Singapore Pte. Ltd. bought a new position in shares of Ardent Health Partners in the fourth quarter valued at approximately $27,000. US Bancorp DE acquired a new position in Ardent Health Partners in the 4th quarter valued at $31,000. R Squared Ltd bought a new position in Ardent Health Partners in the 4th quarter worth $37,000. BNP Paribas Financial Markets acquired a new position in Ardent Health Partners during the 3rd quarter worth $42,000. Finally, New York State Common Retirement Fund bought a new stake in Ardent Health Partners during the fourth quarter valued at about $48,000.

Ardent Health Partners Company Profile

(Get Free Report)

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.

Featured Articles

Should You Invest $1,000 in Ardent Health Partners Right Now?

Before you consider Ardent Health Partners, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ardent Health Partners wasn't on the list.

While Ardent Health Partners currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

5 International Stocks to Escape U.S. Market Volatility

5 International Stocks to Escape U.S. Market Volatility

MarketBeat’s Chris Markoch shares 5 international stock picks that could offer protection—and potential opportunity—amid the current market uncertainty.

Related Videos

3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
3 AI Stocks to Watch After NVIDIA’s Dip

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads